CD19 CAR-T therapy (targeted CD19/CD19-BCMA)

CD19-targeted CAR-T therapy · Nanjing Bioheng Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 CAR-T therapy (targeted CD19/CD19-BCMA), covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]